EP3565553
INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.12.2017EP published:
26.4.2023EP application number:
17890478.5
EPO information:
European Patent Register
Max expiry date:
28.12.2037
Title in English:
INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCERLanguage of the patent:
English
Timeline
Today
29.12.2017EP application
26.4.2023EP Publication
Owner
Name:
Santen Pharmaceutical Co., Ltd.Address:
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku Osaka-shi Osaka 533-8651, JP
Inventor
Name:
KUNDU, AishwaryaAddress:
Emeryville California 94608, US
Name:
ESCUDERO, CecileAddress:
Emeryville California 94608, US
Name:
MUDUMBA, SreenivasuAddress:
Emeryville California 94608, US
Priority
Number:
201762443599 PDate:
6.1.2017Country:
US
Classification
Categories:
A61K 31/436, A61K 9/08, A61K 47/10, A61K 47/18, A61K 47/20, A61K 47/22, A61K 47/24, A61K 47/26, A61K 47/34, A61K 47/36, A61P 35/00, A61K 45/06